IRQ Articles

New Horizons in IR 

04-27-2021 10:24

AD: Boston Scientific
SIR Today 2021 banner

SIR is pleased to announce the upcoming IR Quarterly supplement, "New Horizons in IR." You'll find articles on emerging techniques, a timeline celebrating the context for these treatments of tomorrow, and predictions from the community of what comes next for the culture and science of IR.

 

Introducing: New Horizons in IR

Roger T. Tomihama, MD

 

Genicular artery intervention: The future standard of care for inflammatory conditions

The role of genicular artery embolization in decreasing pain and disability resulting from osteoarthritis-related knee pain is expanding, and may have possible applications for other inflammatory musculoskeletal conditions.
Sandeep Bagla, MD

TACE and immunotherapy for intermediate-stage HCC: "TIME" for combination trials?

Updates on the current state of adjunctive immunotherapy in liver-directed therapy for hepatocellular carcinoma.
Jacob Dayan, MD, and Joseph P. Erinjeri, MD, PhD

Bariatric embolization: An emerging minimally invasive therapy for patients with obesity

 A look at the potential of bariatric embolization in treating obesity, the outcomes of the recent SIR Foundation RCP on the treatment, and the next steps forward.
Frank Yuan, MD, and Clifford R. Weiss, MD, FSIR

The venous revolution: Where we are and where we're going

Learn about recent advances in venous reconstruction, superficial venous disease management, thrombectomy and venous reconstruction and more.
David S. Shin, MD; Frederick Bertino, MD; Ramsey A. Al-Hakim, MD; Ronald S. Winokur, MD, FSIR; Kush R. Desai, MD, FSIR; Jeffrey Forris Beecham Chick, MD, MPH

 

The history of innovation

Interventional radiology is a specialty that redefines innovation. This timeline showcases the major events in IR history, from the first angioplasty to the recognition of IR as an independent specialty.


We hope you enjoy this supplement, and want to hear your thoughts on the future of IR. Start the conversation on SIR Connect, tweet us at @SIRSpecialists, and email us anytime with ideas for future IRQ supplements or anything else you’d like to see covered at irq@sirweb.org.

Connect with SIR

AD: Medtronic

ADVERTISEMENT